Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Tumor of Bone”

1,041 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,041 results

Not applicableNot Yet RecruitingNCT06495580
What this trial is testing

Optic Nerve Stimulation To Prevent Visual Deficits After Endoscopic Cranial Approaches

Who this might be right for
Optic Nerve InjuriesSellar TumorSkull Base Neoplasms
University of California, San Francisco 20
Not applicableEnded earlyNCT02354326
What this trial is testing

Dual Energy Computed Tomography (CT) in Finding Bone Metastases in Patients With Cancer

Who this might be right for
Malignant NeoplasmMetastatic Malignant Neoplasm to the Bone
Case Comprehensive Cancer Center 16
Not applicableEnded earlyNCT04740749
What this trial is testing

Longevity, Functional Status and Quality of Life of the Compress® Compliant Pre-Stress System

Who this might be right for
Compress Compliant Pre-Stress SystemMalignant Bone Tumor
Universitaire Ziekenhuizen KU Leuven 200
Not applicableUnknownNCT00295997
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia

Who this might be right for
Chronic Myeloproliferative DisordersKidney CancerLeukemia+4 more
University of California, San Francisco 35
Early research (Phase 1)WithdrawnNCT01130623
What this trial is testing

A Phase I Study of Pazopanib as a Single Agent for Children With Refractory Solid Tumors

Who this might be right for
SarcomaNeuroblastomaWilms Tumor+2 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00005946
What this trial is testing

Chemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell Transplantation

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
University of Maryland, Baltimore
Testing effectiveness (Phase 2)UnknownNCT05019794
What this trial is testing

Infigratinib in Subjects With GC or GEJ With FGFR2 Amplification or Other Solid Tumors With Other FGFR Alterations

Who this might be right for
Gastric CancerGastroesophageal Junction AdenocarcinomaSolid Tumor
LianBio LLC 80
Not applicableLooking for participantsNCT06987370
What this trial is testing

SFRT and SCART in Radiotherapy for Bone Metastases With Soft Tissue

Who this might be right for
Bone Metastases in Subjects With Advanced Cancer
Shandong Cancer Hospital and Institute 90
Testing effectiveness (Phase 2)Study completedNCT02988466
What this trial is testing

Reduced Intensity (RIC) Conditioning And Transplantation of HLA-Haplo-HCT

Who this might be right for
Hematologic Malignancies
Masonic Cancer Center, University of Minnesota 78
Early research (Phase 1)Study completedNCT00891137
What this trial is testing

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy

Who this might be right for
LeukemiaLymphomaMultiple Myeloma+2 more
Cellerant Therapeutics 30
Early research (Phase 1)Study completedNCT00569283
What this trial is testing

Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant

Who this might be right for
Cancer
Asan Medical Center 18
Testing effectiveness (Phase 2)UnknownNCT01693770
What this trial is testing

Primary Pain Palliation in Bone Metastases Treated With Magnetic Resonance-guided Focused Ultrasound

Who this might be right for
Secondary Malignant Neoplasm of Bone
University of Roma La Sapienza 18
Testing effectiveness (Phase 2)Study completedNCT00002461
What this trial is testing

Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Montefiore Medical Center 35
Early research (Phase 1)Not Yet RecruitingNCT07529951
What this trial is testing

Study of ZE74-0282 for Patients With JAK2 V617F Positive Blood Cancers

Who this might be right for
Polycythemia Vera (PV)Myelofibrosis (MF)
Eilean Therapeutics 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT02867592
What this trial is testing

Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors

Who this might be right for
Adrenal Cortical CarcinomaAlveolar Soft Part SarcomaCentral Nervous System Neoplasm+41 more
National Cancer Institute (NCI) 109
Not applicableStudy completedNCT04956198
What this trial is testing

Drug Sensitivity and Mutation Profiling

Who this might be right for
Ewing SarcomaOsteosarcomaRhabdomyosarcoma+4 more
Florida International University 14
Post-approval studies (Phase 4)WithdrawnNCT02101164
What this trial is testing

Evaluate Time Associated With the Preparation & Administration of Denosumab/Pamidronate in Patients With Solid Tumors and Metastatic Bone Disease

Who this might be right for
Solid TumorMetastatic Bone Disease
Amgen
Post-approval studies (Phase 4)Ended earlyNCT00819832
What this trial is testing

Anderson Circulating Tumor Cell Burden (CTCB) Study

Who this might be right for
CancerSpinal DiseaseVertebral Compression Fractures
M.D. Anderson Cancer Center 3
Early research (Phase 1)Study completedNCT04439006
What this trial is testing

Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization

Who this might be right for
Aplastic AnemiaHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm+4 more
Jennifer Woyach 10
Early research (Phase 1)Active Not RecruitingNCT04328844
What this trial is testing

Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic Cancers

Who this might be right for
Solid Tumor, AdultNon-Hodgkin Lymphoma, AdultNSCLC+2 more
iOnctura 210
Load More Results